Regulation of lipid metabolism by PPARalpha

Stable Identifier
R-HSA-400206
Type
Pathway
Species
Homo sapiens
Compartment
Synonyms
Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser
Peroxisome proliferator-activated receptor alpha (PPAR-alpha) is the major regulator of fatty acid oxidation in the liver. PPARalpha is also the target of fibrate drugs used to treat abnormal plasma lipid levels.
PPAR-alpha is a type II nuclear receptor (its subcellular location does not depend on ligand binding). PPAR-alpha forms heterodimers with Retinoid X receptor alpha (RXR-alpha), another type II nuclear receptor. PPAR-alpha is activated by binding fatty acid ligands, especially polyunsaturated fatty acids having 18-22 carbon groups and 2-6 double bonds.
The PPAR-alpha:RXR-alpha heterodimer binds peroxisome proliferator receptor elements (PPREs) in and around target genes. Binding of fatty acids and synthetic ligands causes a conformational change in PPAR-alpha such that it releases the corepressors and binds coactivators (CBP-SRC-HAT complex, ASC complex, and TRAP-Mediator complex) which initiate transcription of the target genes.
Target genes of PPAR-alpha participate in fatty acid transport, fatty acid oxidation, triglyceride clearance, lipoprotein production, and cholesterol homeostasis.
Literature References
PubMed ID Title Journal Year
18288277 Peroxisome proliferator activated receptors and lipoprotein metabolism

Kersten, S

PPAR Res 2008
10529898 Peroxisome proliferator-activated receptors: nuclear control of metabolism

Wahli, W, Desvergne, B

Endocr Rev 1999
16476485 From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions

Gelman, L, Wahli, W, Michalik, L, Desvergne, B, Feige, JN

Prog Lipid Res 2006
16503871 Peroxisome proliferator-activated receptor alpha (PPARalpha) and athero-sclerosis

Gouni-Berthold, I, Krone, W

Curr Drug Targets Cardiovasc Haematol Disord 2005
Participants
Participates
Event Information
Orthologous Events
Authored
Reviewed
Created
Cite Us!